Regenxbio
Price & Volume
Stats
See more52W Range | $5.03-$17.52 |
Market Cap | $461M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $83.3M |
Revenue Growth (YoY) | -4.5% |
Gross Profit (12 Mos) | $49.7M |
Diluted EPS | -$4.59 |
News
See moreYahoo Finance • last year
REGENXBIO Announces Positive Interim Data from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery
Yahoo Finance • last year
Regenxbio Inc President and CEO Kenneth Mills Sells 45,000 Shares
Yahoo Finance • last year
REGENXBIO Inc. (NASDAQ:RGNX) Q3 2023 Earnings Call Transcript
Yahoo Finance • last year
REGENXBIO Announces Updated Strategic Plans and Third Quarter 2023 Financial Results
About
CEO | Mr. Curran M. Simpson M.S. |
CFO | Mr. Mitchell Chan M.B.A. |
Address | 9804 Medical Center Drive, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 353 |
